Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.00    0.00 (0.00%)
Bid:
228.00
Ask:
229.00
Spread: 1.00 (0.439%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

10 May 2011 07:00

RNS Number : 2473G
Morgan Crucible Co PLC
10 May 2011
 



Press Release

Interim Management Statement 

The Morgan Crucible Company plc

10th May 2011

 

 

The Morgan Crucible Company plc ('Morgan Crucible'), the advanced materials company, is today holding its annual general meeting and issuing its 'Interim Management Statement' regarding trading for the first four months of 2011 and outlook for the full year 2011.

 

·; The Group has performed better than previously expected in the first four months of the year with good trading momentum across its end markets and geographies

 

·; In the four month period to April revenue increased by c.10%, at reported rates, against the comparable period last year, although year on year comparisons will become increasingly challenging as 2011 progresses

 

·; Net restructuring and one-off costs are now expected to be less than £5 million in 2011, the majority of which will be incurred in the first half of the year

 

·; Underlying operating profit margins (EBITA post restructuring and one-off costs) continued to improve, driven by positive trading and ongoing operational initiatives

 

·; In April, the Group refinanced its bank facilities with a new 5 year, £150 million revolving credit facility

 

 

Outlook

 

The good trading momentum, which was broadly based across end markets and geographies, together with improving performance in the first four months of the year give the Group confidence in being modestly ahead of expectations at the half year. The outlook for the full year also remains positive based on the performance to date.

 

 

Ceramics Division

 

The Ceramics Division consists of the Technical Ceramics and Thermal Ceramics businesses that were merged in the second half of 2010.

 

The Technical Ceramics business has made a good start to 2011. The improved market conditions in the second half of 2010 across all geographies have continued through the first four months of this year. The aerospace and general industrial markets have been particularly robust. The investments made in 2010 for next generation HDD products are operational and supporting the production ramp which continues in line with our expectations.

 

As anticipated, our later cycle Thermal Ceramics business has continued to see a recovery in its markets which we saw coming through at the end of 2010 and the recovery of these markets and geographies remains in line with our expectations.

 

Work on reducing our cost base from the merger of the Thermal and Technical businesses continues. We are on track to deliver the anticipated £5 million benefits we planned for 2011.

 

The order intake has been encouragingly positive across the Division.

 

 

Engineered Materials

 

The Engineered Materials Division consists of the Advanced Materials and Technology (AM&T) business, including NP Aerospace, and the Molten Metal Systems (MMS) business.

 

The first four months of 2011 has seen good performance from AM&T (excluding NP Aerospace) with revenue well above 2010 levels and strong order book intake. The business in China continues to grow at a rapid pace and is on track for another year of very good growth. Demand in America continues to improve across most sectors and trading conditions in Europe are beginning to show signs of further improvement. The electrical and seal & bearing businesses continue to trade well, maintaining the momentum from 2010 and nearing pre-recession levels. Clean energy initiatives are continuing to generate results. Our high temperature order book and revenues have grown robustly from the start of the year and are anticipated to continue growing throughout the remainder of the year. The lithium ion acquisition, Hairong (China), has begun the year as anticipated, while wind revenue continues to increase with further business wins across the world.

 

As expected, NP Aerospace is trading below 2010 levels. Our robust order intake in both vehicle and personal protection provides good visibility and confidence that full year revenue will be in line with previous guidance at c.£90 million. We remain focused on expanding our market presence beyond the UK and our efforts have recently resulted in a first prototype order from a major US vehicle OEM.

 

MMS revenue to April was well ahead of the comparable period last year with order intake also healthy. We continue to deliver strong growth from India and China where our low cost manufacturing bases are also facilitating operational efficiency improvements.

 

 

Financial position

 

There have been no material changes to the financial position of the Group in the first four months of 2011. The refinancing of the bank revolver was successfully completed in April with a £150 million facility at improved pricing terms, with all eight relationship banks who had participated in the previous facility.

 

The net restructuring and one off costs for 2011 are now expected to be less than £5 million. Costs of restructuring of c.£7 million are now expected to be offset by the sale of excess land and buildings in the first half and anticipated further sales in the second half of the year.

 

 

For further enquiries:

Mark Robertshaw

Morgan Crucible

01753 837000

Kevin Dangerfield

Morgan Crucible

01753 837000

 

 

 

Rollo Head/Clare Hunt

Finsbury

020 7251 3801

 

 

This statement constitutes Morgan Crucible's Interim Management Statement for the period from 3rd January 2011 to 9th May 2011 as required by the UK Listing Authority's Disclosure and Transparency Rules.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBRGDUUGGBGBC
Date   Source Headline
28th Apr 20209:15 amRNSDisclosure of Rights Attached to Listed Securities
9th Apr 20201:33 pmRNSNotice of AGM
2nd Apr 20205:01 pmRNSDirector/PDMR Shareholding
1st Apr 20201:04 pmRNSAnnual Financial Report
31st Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:39 pmRNSPrice Monitoring Extension
19th Mar 202012:22 pmRNSDirector/PDMR Shareholding
12th Mar 202010:14 amRNSDirector/PDMR Shareholding
11th Mar 202010:57 amRNSDirector/PDMR Shareholding
3rd Mar 20205:29 pmRNSDirector/PDMR Shareholding
25th Feb 20207:00 amRNSFull-year Results
16th Dec 20199:10 amRNSBlock listing Interim Review
2nd Dec 20199:10 amRNSDirector Declaration
18th Nov 201911:00 amRNSDirector/PDMR Shareholding
13th Nov 20199:48 amRNSDirector/PDMR Shareholding
12th Nov 201912:23 pmRNSDirector/PDMR Shareholding
11th Nov 20194:04 pmRNSDirector/PDMR Shareholding
11th Nov 20192:44 pmRNSDirector/PDMR Shareholding
8th Nov 20197:00 amRNSTrading Update
23rd Oct 20191:56 pmRNSHolding(s) in Company
23rd Oct 20191:54 pmRNSHolding(s) in Company
23rd Sep 201912:03 pmRNSDirector/PDMR Shareholding
3rd Sep 20192:21 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSHalf-year Report
17th Jun 20198:06 amRNSBlock listing Interim Review
7th Jun 20199:38 amRNSHolding(s) in Company
24th May 20191:08 pmRNSDirector/PDMR Shareholding
10th May 201912:14 pmRNSResult of AGM
10th May 20197:00 amRNSTrading Update
7th May 20194:36 pmRNSDirectorate Change
8th Apr 20195:29 pmRNSDirector/PDMR Shareholding
3rd Apr 201911:22 amRNSAnnual Financial Report
19th Mar 20199:47 amRNSDirector/PDMR Shareholding
19th Mar 20199:44 amRNSDirector/PDMR Shareholding
26th Feb 20197:00 amRNSFinal Results
17th Dec 201810:51 amRNSBlock listing Interim Review
21st Nov 20182:36 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSDivestment of Composites and Defence Systems
9th Nov 20187:00 amRNSTrading Update
22nd Oct 20185:17 pmRNSHolding(s) in Company
28th Sep 20188:17 amRNSCompletion of Bank Refinancing
6th Aug 20189:24 amRNSDirector/PDMR Shareholding
1st Aug 20188:54 amRNSDirector/PDMR Shareholding
26th Jul 20187:00 amRNSHalf-year results
2nd Jul 20182:37 pmRNS2017 Environmental, Health and Safety Report
2nd Jul 20187:00 amRNSDirectorate Change
15th Jun 20189:00 amRNSBlock listing Interim Review
11th May 20181:32 pmRNSResult of AGM
1st May 20182:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.